Immunotherapy Against Lung Cancers: Emerging Opportunities and Challenges

Dr. Shvetank Bhatt is currently working as an associate professor in School of Pharmacy, Dr. Vishwanath Karad MIT World Peace University, Pune, Maharashtra, India. He has done M.Pharm in pharmacology from Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Karnataka and Ph.D. in neuropharmacology from Birla Institute of Technology & Science (BITS) Pilani, Pilani Campus, Rajasthan. He has total 16 years of industrial and academic research experience. His area of specialization is CNS disorders, pain, inflammation and immunooncology. He is recipient of Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award (Best Paper in Pharmacology-IJPER) in 2012 and 2014. He has published more than 80 papers in various journals of national and international repute. He is life member of Association of Pharmaceutical Teachers of India (APTI) and Indian Pharmacological Society (IPS).

Dr. Rajaraman Eri is a veterinarian turned biomedical scientist who specializes in research investigations into colorectal cancer, functional foods (dietary fibre), clinical nutrition and gut health. Raj was awarded a master’s degree in Veterinary Medicine (TN Veterinary and Animal Sciences University, India) followed by his PhD from the University of Queensland in molecular and cell biology in 2001. His subsequent postdoctoral training USA included research work mainly investigating both innate and adaptive immune responses and associated aspects of clinical translation. Between 2006 and 2010, Dr. Raj joined UQ-Mater Medical research Institute, Brisbane as a senior research officer where he was involved in ground-breaking work illustrating the role of endoplasmic reticulum stress in the pathogenesis of bowel diseases. In late 2010, he joined UTAS as an independent investigator developing a research laboratory dedicated to gut health, establishing an international reputation in this area over a decade. On the teaching side, he coordinates and teaches in the fields of biosciences, immunology, nutrition, and biochemistry. Dr. Raj has won multiple teaching awards including the Australian national citation for excellence in teaching in 2017.

Assoc Prof Goh is a leader and Principal Investigator of Biofunctional Molecule Exploratory Research Group (BMEX), School of Pharmacy, Monash University (Malaysia). His current research focuses on the study of functionality of natural products. His great commitment to academic has earned him the prestigious award of Chartered Biologist (CBiol) status from Royal Society of Biology, United Kingdom & Top 10 Outstanding Young Malaysian by JCI in Year 2020. Dr. Andreoli Pinto´s educational background is in Pharmaceutical Sciences (Bachelor, Master’s and Ph.D.). Her career is more than 40 years of sound experience in Academia, being currently Full Professor in one of the most prestigious Universities in Brazil: University of Sao Paulo. Prof. Terezinha, how she likes to be called, develops and run research on Dosage Forms, focusing on Parenterals (formulation, analytical, microbiological and performance methods) and Medical Devices. Under her supervision, out of 50 researchers concluded their scientific investigations and Prof. Terezinha authored 180 articles in scientific journals, over 12 book chapters - being the most recent ＂Sterilization: Ethylene Oxide＂ (Pinto, T.J.A.; Eduardo, C.L.C.), published in the 4th of Encyclopedia of Pharmaceutical Science and Technology (Taylor & Francis, 2013) and authored the book ＂Biological Quality Control of Drug Products, Medical Devices and Cosmetics＂ (Pinto, T.J.A.; Kaneko, T.M.; Pinto, A.F.), which became a reference in Brazil. Along her career, Prof. Terezinha took management roles in the University, such as being Dean of School of Pharmacy for two mandates (2004-2008 and 2012-2016) and being Chair of Deliberative Board of FURP - a pharmaceutical industry that manufactures products from the WHO Essential Medicines List and is run by Sao Paulo State Government. Strong scientific skills allied to leadership and management allowed her to establish agreements with internationally prestigious institutions (Universities of Alberta, Lisbon and Bath) as well as some important national scientific and educational institutions.

Dr Keshav Raj Paudel is an IASLC early career researcher at the Centre for Inflammation, Centenary Institute/UTS. He completed his Ph.D. (2017) from Mokpo National University, South Korea and started his first postdoctoral research at the University of Texas Health Science Centre at Houston Texas, USA-2018 on a NIH funded project. He is an emerging scientist with a good scientific track records demonstrated through his publications and successful grants. After joining UTS in 2019 for a second^ ＄435K) including IASLC ECR fellowship-2019 (lead CI), SPHERE seed grant-2020 (co-CI), UTS seed grant-2021 (co-CI). He has published more ^ 50% as first/s^50% with CI-Dua and AI-Hansbro) in leading journals such as Cell reports, Antioxidants, Medical Journal of Australia and Nanomedicine. He has also published nano-formulation based original research work in various peer reviewed journal (Life Sciences, Toxicology in vitro, Future Medicinal Chemistry, Tuberculosis, Journal of Food Biochemistry). He is also a journal reviewer of more than 50 journals.

Dr. Kamal Dua is a senior lecturer in the discipline of pharmacy at the Graduate School of Health, University of Technology Sydney (UTS), Australia. He has research experience of over 13 years in the field of drug delivery systems targeting inflammatory diseases. Dr. Dua is also a node leader of drug delivery research in the Centre for Inflammation at Centenary Institute/UTS, where the targets identified from the research projects are pursued to develop novel formulations as the first step towards translation into clinics. Dr. Dua research in two complementary areas; drug delivery and immunology, specifically addressing how these disciplines can advance one another, helping the community to live longer and healthier. This is evidenced by his extensive publication record in reputed journals. Dr. Dua’s research interests focus on harnessing the pharmaceutical potential of modulating critical regulators such as interleukins and microRNAs and developing new and effective drug delivery formulations for the management of chronic airway diseases. He has published more than 100 research articles in peer-reviewed international journals and authored or co-authored four books. He is an active member of many national and international professional societies.